What type of study is this?

This is a Literature Review study.

September 5, 2025Open Access

Research Progress of Metronomic Chemotherapy in the Treatment of Elderly Cancer Patients

YWYizhu WangYanbian University of Science and Technology

Key Points

Metronomic chemotherapy significantly improves quality of life for elderly patients with cancer, reducing side effects.
Elderly individuals (≥60 years) account for 55.8% of new cancer cases in China, indicating a pressing public health concern.
The review outlines the advantages of metronomic approaches over traditional methods, emphasizing consistent, low-dose treatments.
Fostering enhanced patient compliance, metronomic chemotherapy represents a promising avenue for elderly cancer treatment solutions.

Abstract

In China, elderly individuals (≥60 years) face a growing cancer burden, accounting for 55.8% of new cases and 68.2% of deaths. Metronomic chemotherapy offers a promising approach by using continuous low-dose treatment to inhibit tumor growth with fewer side effects. breaking through the cycle-dependent limitations of traditional chemotherapy, this review discusses its applications and benefits for elderly cancer patients, aiming to support clinical practice, at the same time, significantly improves patient compliance and the quality of life of elderly patients.

Ask AI

Helpful

Bookmark

View Full Paper